Popular on TelAve
- Community Redevelopment Inc.Signs Gold Production Contract with Mine CA Gold Ltd., - 175
- CCHR: Why Psychiatric Detainment and Drugging Cannot Deliver Public Safety - 162
- Two Weeks Left: Secure Your Spot at the First OpenSSL Conference 2025 in Prague - 161
- NFL Yearbook Advertising Deal Signed Across 25 Stadiums for AI Powered Sports, Entertainment and Gaming Leader: SEGG Media $SEGG - 153
- Olga Torres Named to the 2025 Texas Super Lawyers List - 149
- Boston Industrial Solutions Introduces Natron® UVPX Series UV-LED Curing Screen Printing Inks - 148
- Powerful Points Illustrate Highly Undervalued Stock Price for Global Communications Leader: IQSTEL, Inc. (N A S D A Q: IQST) - 146
- DB Landscape Co. Brings Modern Outdoor Living to Coastal Communities - 146
- PlaceBased Expands NYC Presence with Strategic DOOH/OOH Asset Growth and Appoints OOH Industry Veteran Scott Nemeroff as EVP of National Accounts - 145
- Planetary Constitution Celebrates First Anniversary as Space Policy Shifts Toward Militarization - 141
Similar on TelAve
- Tami Goveia Enters FabOver40, Inspiring Hollywood Legacy for Breast Cancer Cause
- MDRN MUSE Expands Insurance Network Coverage to Include Delta Dental & Cigna
- Physician Calls for States Nationwide to Ensure ADA Compliance in Independent Commissions
- MEDIA ADVISORY - Strengthening Children's Mental Health Across New Jersey
- America Anesthesia Partners Unveils New User-Friendly Website
- Hiclean Tools Releases HCX2100 Electric Pressure Washer
- ARCH Dental + Aesthetics Offers Free Consultations for New Patients
- New You Smile Dental Implant Center Expands Office
- Essential Living Support Opens First VA Medical Foster Home in Cheyenne, Wyoming
- LSC Destruction Launches Cutting-Edge Cryptocurrency Scanning to Hard Drive Destruction Services
CCHR: Prescription Psychotropics Fuel America's Addiction and Overdose Crisis
TelAve News/10876957
More than 79 million Americans take psychotropics—millions abuse them, risking overdose—yet the $26 billion psychiatric drug industry's role in the failed war on drugs remains downplayed due to widespread misinformation.
LOS ANGELES - TelAve -- By CCHR International
The abuse of prescription psychotropic drugs has become a global public health issue and, according to the mental health industry watchdog Citizens Commission on Human Rights International (CCHR), it is a major factor in the failure of America's war on drugs. More than 79 million Americans are prescribed psychotropics—many of which can cause dependence, respiratory depression, seizures, and fatal outcomes, especially when combined with other substances.[1] Since 1999, drug overdoses have killed more than one million people in the U.S. In 2021 alone, 32,537 overdose deaths involved stimulants such as cocaine or prescription psychostimulants—a staggering 5,848% increase from 547 deaths in 1999.[2]
Prescription Abuse Epidemic
The National Center for Drug Abuse Statistics reports that 5.9 million Americans abuse sedatives, 4.9 million abuse stimulants, and 4.8 million abuse benzodiazepines. Two million people—nearly 12% of misusers—are addicted. First-time abusers often start with sedatives or tranquilizers, accounting for more than 32% of initial misuse.[3]
Among stimulant abusers, amphetamine/dextroamphetamine is the most frequently misused (75.8% usage rate), followed by methylphenidate at 24.5%.[4] Both drugs are prescribed for Attention Deficit Hyperactivity Disorder (ADHD)—a behavioral construct, not a medically validated disease, or illness that can be cured by a drug. More than 9.5 million Americans are prescribed ADHD stimulants, including 3.1 million minors.[5]
Adult stimulant prescriptions surged 34% between 2019 and 2022. A JAMA Psychiatry study of 84,000 adults (18–64) found that one in four prescribed stimulants abused them.[6] Today, more than half (51%) of stimulant abusers are aged 26 or older.[7] According to IQVIA data, adults aged 31–40, particularly women, and older adults (41–70) saw the steepest rise in stimulant prescribing between 2012 and 2023.[8]
Psychiatric Prescribing Trends & Abuse
In 2022, psychiatrists, pediatricians, and nurse practitioners continued to be the most common prescribers of stimulants.[9] A Medical Expenditure Panel Survey (2016–2019) showed psychiatrists prescribed 33.5% of psychotropics, while general practitioners, nurse practitioners, and physician assistants combined wrote more than 60%.[10] From 2021 to 2023, stimulant marketing payments to physicians doubled from $1.8 million to $3.6 million. The increases were driven in large part by growth in marketing to psychiatrists (a 250% increase). A recent analysis of industry payment data showed that more than $12 billion in payments were made to physicians from 2013 to 2022.[11] Jan Eastgate, President of CCHR International, says, "IQVIA reports U.S. psychiatric drug sales have reached $25.8 billion—underscoring how prescribing and marketing incentives drive a highly lucrative business."
More on TelAve News
The long-term effects of stimulant abuse include heart attack, stroke, seizures, liver and kidney damage, arrhythmia, coma, and death. Sedatives and tranquilizers also carry high risks, including liver failure, amnesia, nightmares, vision loss, depression, and death.[12]
From 2006 to 2023, SSRI antidepressant use among children and adolescents (ages 3–17) rose from 1.5% to 3.6%. Adult prescribing has steadily increased across four major psychotropic classes.[13] The journal Pharmaceuticals warns of SSRI dependence and withdrawal, affecting 55–65% of users.[14] In 2023, SSRIs were implicated in 64,993 single-substance toxic exposures reported to U.S. poison centers, including 285 major outcomes and three fatalities. Rates of SSRI ingestion mirror rising prescription levels.[15]
Misinformation about addiction risks and the perception that prescription drugs are "safer than street drugs" help drive abuse of them.[16] Sixty-two percent of teenagers admitted to abusing prescriptions because they were easily obtained from parents' medicine cabinets, while 35% said they believed prescriptions were safer than illegal substances.[17] College initiates often misuse stimulants as "study aids," while pre-college initiates abuse them recreationally.[18]
CCHR warns that psychiatric diagnostic expansion—driven by the Diagnostic and Statistical Manual of Mental Disorders (DSM)—inflates disorder rates and fuels prescription demand. It criticizes a system in which psychiatrists with financial ties to the pharmaceutical industry vote on which disorders to include.
As Professors Herb Kutchins and Stuart A. Kirk wrote in Making Us Crazy, "DSM is used to directly affect national health policy and priorities by inflating the proportion of the population that is defined as 'mentally disordered.'"[19] These inflated figures drive mental health budgets and prescribing.
The rise of telehealth and e-prescribing, direct-to-consumer (DTC) marketing strategies and subscription-based models—enabled by DSM-based diagnoses—have fueled a surge of direct-to-consumer platforms aggressively marketing adult ADHD treatment through subscription-based models. Both the Drug Enforcement Administration and the Food and Drug Administration have raised concerns over diversion and misuse from such services.[20]
CCHR, established in 1969 by the Church of Scientology and psychiatrist Prof. Thomas Szasz, says urgent action is needed to end the aggressive marketing of psychotropic drugs and the false perception that prescriptions guarantee safety. It emphasizes that people need to be informed that no medical test can confirm a mental disorder, while recognizing that emotional distress is real and can be severe. The watchdog warns that youth, in particular, must be alerted that these drugs carry grave risks of dependence, abuse, and overdose—even when obtained legally from a doctor or psychiatrist.
More on TelAve News
Sources:
[1] "Prevalence and risk factors for misuse of prescription psychotropic drug in patients with severe mental illness: A systematic review," Actas Esp Psiquiatr. 1 Sept. 2023, pmc.ncbi.nlm.nih.gov/articles/PMC10803847/
[2] www.cchrint.org/2023/03/10/cchr-calls-for-more-oversight-after-recent-addiction-treatment-center-closures/
[3] drugabusestatistics.org/prescription-drug-abuse-statistics/
[4] drugabusestatistics.org/prescription-drug-abuse-statistics/
[5] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/; www.cchrint.org/psychiatric-drugs/children-on-psychiatric-drugs/
[6] www.webmd.com/add-adhd/news/20250409/america-may-have-a-new-rx-drug-crisis-are-you-part-of-it
[7] drugabusestatistics.org/prescription-drug-abuse-statistics/
[8] "Stimulant Prescription Trends in the United States From 2012-2023," IQVIA Government Solutions, Inc., prepared for the DEA, 13 Nov 2023, pp. 4-5
[9] Ibid.
[10] Psychotropic Medication Prescribing Across Medical Providers, 2016–2019, Psychiatry OnLine, 20 Nov. 2023; www.psychiatryonline.org/doi/10.1176/appi.ps.20230156
[11] www.medpagetoday.com/pediatrics/adhd-add/117138
[12] drugabusestatistics.org/prescription-drug-abuse-statistics/
[13] "U.S. Population Prevalence of Prescription Psychiatric Medication Use Among Children and Adolescents, 2006-2023," ASPE, Office of the Assistant Secretary for Planning and Evaluation, 4 Aug. 2025, aspe.hhs.gov/reports/psychotropic-medication-among-children-adolescents
[14] "A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases," Pharmaceuticals, May 2022, pmc.ncbi.nlm.nih.gov/articles/PMC9146999/
[15] "Selective serotonin reuptake inhibitor poisoning," www.uptodate.com/contents/selective-serotonin-reuptake-inhibitor-poisoning
[16] www.ascendhc.com/teen-rehab-blog/prescription-pills-abuse/
[17] drugabusestatistics.org/prescription-drug-abuse-statistics/
[18] drugabusestatistics.org/prescription-drug-abuse-statistics/
[19] Herb Kutchins and Stuart A. Kirk, Making Us Crazy: The Psychiatric Bible and the Creation of Mental Disorders (The Free Press, New York, 1997), p. 243
[20] www.trillianthealth.com/market-research/studies/increases-in-adult-adhd-diagnosis-and-off-label-stimulant-prescribing
The abuse of prescription psychotropic drugs has become a global public health issue and, according to the mental health industry watchdog Citizens Commission on Human Rights International (CCHR), it is a major factor in the failure of America's war on drugs. More than 79 million Americans are prescribed psychotropics—many of which can cause dependence, respiratory depression, seizures, and fatal outcomes, especially when combined with other substances.[1] Since 1999, drug overdoses have killed more than one million people in the U.S. In 2021 alone, 32,537 overdose deaths involved stimulants such as cocaine or prescription psychostimulants—a staggering 5,848% increase from 547 deaths in 1999.[2]
Prescription Abuse Epidemic
The National Center for Drug Abuse Statistics reports that 5.9 million Americans abuse sedatives, 4.9 million abuse stimulants, and 4.8 million abuse benzodiazepines. Two million people—nearly 12% of misusers—are addicted. First-time abusers often start with sedatives or tranquilizers, accounting for more than 32% of initial misuse.[3]
Among stimulant abusers, amphetamine/dextroamphetamine is the most frequently misused (75.8% usage rate), followed by methylphenidate at 24.5%.[4] Both drugs are prescribed for Attention Deficit Hyperactivity Disorder (ADHD)—a behavioral construct, not a medically validated disease, or illness that can be cured by a drug. More than 9.5 million Americans are prescribed ADHD stimulants, including 3.1 million minors.[5]
Adult stimulant prescriptions surged 34% between 2019 and 2022. A JAMA Psychiatry study of 84,000 adults (18–64) found that one in four prescribed stimulants abused them.[6] Today, more than half (51%) of stimulant abusers are aged 26 or older.[7] According to IQVIA data, adults aged 31–40, particularly women, and older adults (41–70) saw the steepest rise in stimulant prescribing between 2012 and 2023.[8]
Psychiatric Prescribing Trends & Abuse
In 2022, psychiatrists, pediatricians, and nurse practitioners continued to be the most common prescribers of stimulants.[9] A Medical Expenditure Panel Survey (2016–2019) showed psychiatrists prescribed 33.5% of psychotropics, while general practitioners, nurse practitioners, and physician assistants combined wrote more than 60%.[10] From 2021 to 2023, stimulant marketing payments to physicians doubled from $1.8 million to $3.6 million. The increases were driven in large part by growth in marketing to psychiatrists (a 250% increase). A recent analysis of industry payment data showed that more than $12 billion in payments were made to physicians from 2013 to 2022.[11] Jan Eastgate, President of CCHR International, says, "IQVIA reports U.S. psychiatric drug sales have reached $25.8 billion—underscoring how prescribing and marketing incentives drive a highly lucrative business."
More on TelAve News
- Phinge Mobile Pop-Up Stores Previewing Its Patented Modular Earbuds & Magnetically Connectable Phones, Tablets & Gaming Systems, Coming to Your Town
- Physician Calls for States Nationwide to Ensure ADA Compliance in Independent Commissions
- MEDIA ADVISORY - Strengthening Children's Mental Health Across New Jersey
- Stop Paying Cloud Storage Fees: Make Money From Your Data That You Own, Through Netverse Verified App-less Platform & Hardware From Phinge
- NumberSquad Launches Year‑Round Tax Planning Package for Small Businesses and the Self‑Employed
The long-term effects of stimulant abuse include heart attack, stroke, seizures, liver and kidney damage, arrhythmia, coma, and death. Sedatives and tranquilizers also carry high risks, including liver failure, amnesia, nightmares, vision loss, depression, and death.[12]
From 2006 to 2023, SSRI antidepressant use among children and adolescents (ages 3–17) rose from 1.5% to 3.6%. Adult prescribing has steadily increased across four major psychotropic classes.[13] The journal Pharmaceuticals warns of SSRI dependence and withdrawal, affecting 55–65% of users.[14] In 2023, SSRIs were implicated in 64,993 single-substance toxic exposures reported to U.S. poison centers, including 285 major outcomes and three fatalities. Rates of SSRI ingestion mirror rising prescription levels.[15]
Misinformation about addiction risks and the perception that prescription drugs are "safer than street drugs" help drive abuse of them.[16] Sixty-two percent of teenagers admitted to abusing prescriptions because they were easily obtained from parents' medicine cabinets, while 35% said they believed prescriptions were safer than illegal substances.[17] College initiates often misuse stimulants as "study aids," while pre-college initiates abuse them recreationally.[18]
CCHR warns that psychiatric diagnostic expansion—driven by the Diagnostic and Statistical Manual of Mental Disorders (DSM)—inflates disorder rates and fuels prescription demand. It criticizes a system in which psychiatrists with financial ties to the pharmaceutical industry vote on which disorders to include.
As Professors Herb Kutchins and Stuart A. Kirk wrote in Making Us Crazy, "DSM is used to directly affect national health policy and priorities by inflating the proportion of the population that is defined as 'mentally disordered.'"[19] These inflated figures drive mental health budgets and prescribing.
The rise of telehealth and e-prescribing, direct-to-consumer (DTC) marketing strategies and subscription-based models—enabled by DSM-based diagnoses—have fueled a surge of direct-to-consumer platforms aggressively marketing adult ADHD treatment through subscription-based models. Both the Drug Enforcement Administration and the Food and Drug Administration have raised concerns over diversion and misuse from such services.[20]
CCHR, established in 1969 by the Church of Scientology and psychiatrist Prof. Thomas Szasz, says urgent action is needed to end the aggressive marketing of psychotropic drugs and the false perception that prescriptions guarantee safety. It emphasizes that people need to be informed that no medical test can confirm a mental disorder, while recognizing that emotional distress is real and can be severe. The watchdog warns that youth, in particular, must be alerted that these drugs carry grave risks of dependence, abuse, and overdose—even when obtained legally from a doctor or psychiatrist.
More on TelAve News
- GlexScale launches a unified model for sustainable SaaS expansion across EMEA
- SwagHer Society Launches to Help Black Women Be Seen and Supported
- Why Philadelphia Homeowners Should Ditch Oil for Natural Gas
- Zero-Trust Architecture: NJTRX Addresses 60% of U.S. Investors' Custody Security Concerns
- Sub-Millisecond Trading Platform: HNZLLQ Introduces Unified Gateway for Philippine Digital Asset Traders
Sources:
[1] "Prevalence and risk factors for misuse of prescription psychotropic drug in patients with severe mental illness: A systematic review," Actas Esp Psiquiatr. 1 Sept. 2023, pmc.ncbi.nlm.nih.gov/articles/PMC10803847/
[2] www.cchrint.org/2023/03/10/cchr-calls-for-more-oversight-after-recent-addiction-treatment-center-closures/
[3] drugabusestatistics.org/prescription-drug-abuse-statistics/
[4] drugabusestatistics.org/prescription-drug-abuse-statistics/
[5] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/; www.cchrint.org/psychiatric-drugs/children-on-psychiatric-drugs/
[6] www.webmd.com/add-adhd/news/20250409/america-may-have-a-new-rx-drug-crisis-are-you-part-of-it
[7] drugabusestatistics.org/prescription-drug-abuse-statistics/
[8] "Stimulant Prescription Trends in the United States From 2012-2023," IQVIA Government Solutions, Inc., prepared for the DEA, 13 Nov 2023, pp. 4-5
[9] Ibid.
[10] Psychotropic Medication Prescribing Across Medical Providers, 2016–2019, Psychiatry OnLine, 20 Nov. 2023; www.psychiatryonline.org/doi/10.1176/appi.ps.20230156
[11] www.medpagetoday.com/pediatrics/adhd-add/117138
[12] drugabusestatistics.org/prescription-drug-abuse-statistics/
[13] "U.S. Population Prevalence of Prescription Psychiatric Medication Use Among Children and Adolescents, 2006-2023," ASPE, Office of the Assistant Secretary for Planning and Evaluation, 4 Aug. 2025, aspe.hhs.gov/reports/psychotropic-medication-among-children-adolescents
[14] "A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases," Pharmaceuticals, May 2022, pmc.ncbi.nlm.nih.gov/articles/PMC9146999/
[15] "Selective serotonin reuptake inhibitor poisoning," www.uptodate.com/contents/selective-serotonin-reuptake-inhibitor-poisoning
[16] www.ascendhc.com/teen-rehab-blog/prescription-pills-abuse/
[17] drugabusestatistics.org/prescription-drug-abuse-statistics/
[18] drugabusestatistics.org/prescription-drug-abuse-statistics/
[19] Herb Kutchins and Stuart A. Kirk, Making Us Crazy: The Psychiatric Bible and the Creation of Mental Disorders (The Free Press, New York, 1997), p. 243
[20] www.trillianthealth.com/market-research/studies/increases-in-adult-adhd-diagnosis-and-off-label-stimulant-prescribing
Source: Citizens Commission on Human Rights International
0 Comments
Latest on TelAve News
- Why FIRE Enthusiasts Are Buying Businesses Instead of Just Saving Their Way to Freedom
- All About bail Bonds Expands Presence to Serve Houston Families
- Thousands to Ride to L.A. Children's Hospital This Halloween Night
- Essential Living Support Opens First VA Medical Foster Home in Cheyenne, Wyoming
- Six-Figure Chicks Book Series 96 Authors, 6 Volumes Published to Empower and Mentor Women Nationwide
- LSC Destruction Launches Cutting-Edge Cryptocurrency Scanning to Hard Drive Destruction Services
- $150 Million Financing Initiates N A S D A Q's First Tether Gold Treasury Combining the Stability of Physical Gold with Blockchain $AURE
- Podcast for Midlife Women Entrepreneurs Celebrates 100th Episode with Rhea Lana's Founder and CEO
- What If Help Could Come Before the Fall?
- OddsTrader Examines the NHL Presidents Trophy Curse: Why Regular-Season Success Rarely Leads to Playoff Glory
- Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
- Coming Up this Weekend on CNBC Mike Milligan Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- White Glove Restoration Sends "Help in Boxes" to Support Communities in Ghana